The medical treatment of obsessive-compulsive disorder and anxiety - PubMed

Affiliations

• PMID: 18849910
• DOI: 10.1017/s1092852900026924

Review

The medical treatment of obsessive-compulsive disorder and anxiety

Borwin Bandelow. CNS Spectr. 2008 Sep.

Abstract

Selective serotonin reuptake inhibitors (SSRIs) are first-line pharmacotherapy treatments for obsessive-compulsive disorder (OCD). Clomipramine is effective in OCD but associated with more adverse events. Typically, higher doses of antidepressants are required for OCD. Up to 50% of patients do not respond to initial treatment of OCD. Treatment options for nonresponders include augmentation of antidepressants with atypical antipsychotics, among other strategies. First-line treatments for anxiety disorders include SSRIs, serotonin norepinephrine reuptake inhibitors, and pregabalin. Tricyclic antidepressants are equally effective as SSRIs, but are less well tolerated. In treatment-resistant cases, benzodiazepines may be used when the patient does not have a history of dependency and tolerance. Other treatment options include irreversible and reversible monoamine oxidase inhibitors, the atypical antipsychotic quetiapine, and other medications. Cognitive-behavioral therapy has been sufficiently investigated in controlled studies of OCD and anxiety disorders and is recommended alone or in combination with the above medications.

Similar articles

• [Drug treatment of obsessive-compulsive disorder. With proper drugs and some patience many patients can be helped].

  Mavrogiorgou P, Hegerl U. Mavrogiorgou P, et al. MMW Fortschr Med. 1999 Sep 30;141(39):32-4, 37. MMW Fortschr Med. 1999. PMID: 10897982 German.

• Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part I: pharmacological treatment.

  de Oliveira MVS, de Barros PMF, de Mathis MA, Boavista R, Chacon P, Echevarria MAN, Ferrão YA, Vattimo EFQ, Lopes AC, Torres AR, Diniz JB, Fontenelle LF, Rosário MCD, Shavitt RG, Miguel EC, da Silva RMF, Costa DLDC. de Oliveira MVS, et al. Braz J Psychiatry. 2023 May 11;45(2):146-161. doi: 10.47626/1516-4446-2022-2891. Braz J Psychiatry. 2023. PMID: 36749887 Free PMC article.

• Pharmacological treatment of obsessive-compulsive disorder.

  Pittenger C, Bloch MH. Pittenger C, et al. Psychiatr Clin North Am. 2014 Sep;37(3):375-91. doi: 10.1016/j.psc.2014.05.006. Epub 2014 Jul 24. Psychiatr Clin North Am. 2014. PMID: 25150568 Free PMC article. Review.

• [Evidence-based pharmacotherapy and other somatic treatment approaches for obsessive-compulsive disorder: state of the art].

  Kordon A, Zurowski B, Wahl K, Hohagen F. Kordon A, et al. Nervenarzt. 2011 Mar;82(3):319-20, 322-4. doi: 10.1007/s00115-010-2963-2. Nervenarzt. 2011. PMID: 21340636 Review. German.

• Pharmacotherapy for obsessive compulsive disorder in clinical practice - Data of 842 inpatients from the International AMSP Project between 1994 and 2012.

  Poppe C, Müller ST, Greil W, Walder A, Grohmann R, Stübner S. Poppe C, et al. J Affect Disord. 2016 Aug;200:89-96. doi: 10.1016/j.jad.2016.04.035. Epub 2016 Apr 21. J Affect Disord. 2016. PMID: 27130958

Cited by

• Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials.

  Dold M, Aigner M, Lanzenberger R, Kasper S. Dold M, et al. Int J Neuropsychopharmacol. 2015 May 4;18(9):pyv047. doi: 10.1093/ijnp/pyv047. Int J Neuropsychopharmacol. 2015. PMID: 25939614 Free PMC article.

• A Microglia Sublineage Protects from Sex-Linked Anxiety Symptoms and Obsessive Compulsion.

  Tränkner D, Boulet A, Peden E, Focht R, Van Deren D, Capecchi M. Tränkner D, et al. Cell Rep. 2019 Oct 22;29(4):791-799.e3. doi: 10.1016/j.celrep.2019.09.045. Cell Rep. 2019. PMID: 31644903 Free PMC article.

• N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic review.

  Oliver G, Dean O, Camfield D, Blair-West S, Ng C, Berk M, Sarris J. Oliver G, et al. Clin Psychopharmacol Neurosci. 2015 Apr 30;13(1):12-24. doi: 10.9758/cpn.2015.13.1.12. Clin Psychopharmacol Neurosci. 2015. PMID: 25912534 Free PMC article.

• Cognitive behavioural therapy and third-wave approaches for anxiety and related disorders in older people.

  Hendriks GJ, Janssen N, Robertson L, van Balkom AJ, van Zelst WH, Wolfe S, Oude Voshaar RC, Uphoff E. Hendriks GJ, et al. Cochrane Database Syst Rev. 2024 Jul 8;7(7):CD007674. doi: 10.1002/14651858.CD007674.pub3. Cochrane Database Syst Rev. 2024. PMID: 38973756 Review.

• Development and Psychometric Evaluation of the Treatment-Emergent Activation and Suicidality Assessment Profile.

  Reid JM, Storch EA, Murphy TK, Bodzin D, Mutch PJ, Lehmkuhl H, Aman M, Goodman WK. Reid JM, et al. Child Youth Care Forum. 2010 Feb 4;39(2):113-124. doi: 10.1007/s10566-010-9095-5. Child Youth Care Forum. 2010. PMID: 20473344 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Medical

  • MedlinePlus Health Information